The goal of the Network is to foster a culture of rigorous scientific
comparisons and promote the evaluation of newer surgical techniques,
technologies, devices, and innovative pharmaceutical and bioengineered
products directed at cardiovascular disease. Our network enables
research teams led by cardiac surgeons to evaluate newer therapies and
techniques as they move from laboratory science to broad clinical use.
With support from the National Heart, Lung and Blood Institute at the
NIH we provide the infrastructure to develop, coordinate, and conduct
multiple collaborative proof-of-concept clinical studies and
interventional protocols to improve cardiovascular disease outcomes.
